These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 2816179)

  • 1. The possible enhancement of parvovirus vaccination on the mortality rate of diseased dogs.
    Brenner J; Markus R; Klopfer-Orgad U; Trainin Z
    Zentralbl Veterinarmed B; 1989 Sep; 36(7):547-50. PubMed ID: 2816179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Three-year rabies duration of immunity in dogs following vaccination with a core combination vaccine against canine distemper virus, canine adenovirus type-1, canine parvovirus, and rabies virus.
    Lakshmanan N; Gore TC; Duncan KL; Coyne MJ; Lum MA; Sterner FJ
    Vet Ther; 2006; 7(3):223-31. PubMed ID: 17039445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and serological response of wild dogs (Lycaon pictus) to vaccination against canine distemper, canine parvovirus infection and rabies.
    van Heerden J; Bingham J; van Vuuren M; Burroughs RE; Stylianides E
    J S Afr Vet Assoc; 2002 Mar; 73(1):8-12. PubMed ID: 12088076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a vaccine incorporating killed virus of canine origin for the prevention of canine parvovirus infection.
    Povey C
    Can Vet J; 1982 Jan; 23(1):15-21. PubMed ID: 7039811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of hypertrophic osteodystrophy and antibody response in a litter of vaccinated Weimaraner puppies.
    Harrus S; Waner T; Aizenberg ; Safra N; Mosenco A; Radoshitsky M; Bark H
    J Small Anim Pract; 2002 Jan; 43(1):27-31. PubMed ID: 11833821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The lack of effect of parvovirus vaccination on the seminal characteristics of dogs.
    England GC; Allen WE
    Vet Rec; 1991 Jun; 128(26):611-2. PubMed ID: 1897097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies of parvovirus vaccination in the dog: the performance of live attenuated feline parvovirus vaccines.
    Thompson H; McCandlish IA; Cornwell HJ; Macartney L; Maxwell NS; Weipers AF; Wills IR; Black JA; Mackenzie AC
    Vet Rec; 1988 Apr; 122(16):378-85. PubMed ID: 3394219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The failure of an inactivated mink enteritis virus vaccine in four preparations to provide protection to dogs against challenge with canine parvovirus-2.
    Carman S; Povey C
    Can J Comp Med; 1982 Jan; 46(1):47-50. PubMed ID: 6280820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Parvovirus-vaccination in dogs].
    Osterhaus AD
    Tijdschr Diergeneeskd; 1991 Dec; 116(23):1197-8. PubMed ID: 1661033
    [No Abstract]   [Full Text] [Related]  

  • 10. Field evaluation of a canine parvovirus vaccination program, using feline origin modified live virus vaccine.
    Gordon JC; Rogers WA
    J Am Vet Med Assoc; 1982 Jun; 180(12):1429-31. PubMed ID: 6284689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a modified live, canine origin parvovirus vaccine.
    Bass EP; Gill MA; Beckenhauer WH
    J Am Vet Med Assoc; 1982 Nov; 181(9):909-13. PubMed ID: 7141990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Compatibility of a bivalent modified-live vaccine against Bordetella bronchiseptica and CPiV, and a trivalent modified-live vaccine against CPV, CDV and CAV-2.
    Jacobs AA; Bergman JG; Theelen RP; Jaspers R; Helps JM; Horspool LJ; Paul G
    Vet Rec; 2007 Jan; 160(2):41-5. PubMed ID: 17220520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preliminary development of a live attenuated canine parvovirus vaccine from an isolate of British origin.
    Churchill AE
    Vet Rec; 1987 Apr; 120(14):334-9. PubMed ID: 3035779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of positive antibody test results for canine parvovirus (CPV) and canine distemper virus (CDV) and response to modified live vaccination against CPV and CDV in dogs entering animal shelters.
    Litster A; Nichols J; Volpe A
    Vet Microbiol; 2012 May; 157(1-2):86-90. PubMed ID: 22261239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Canine parvovirus infection potentiates canine distemper encephalitis attributable to modified live-virus vaccine.
    Krakowka S; Olsen RG; Axthelm MK; Rice J; Winters K
    J Am Vet Med Assoc; 1982 Jan; 180(2):137-9. PubMed ID: 7061309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Duration of immunity in dogs inoculated with an inactivated feline parvovirus vaccine.
    Chapek ML; Strauss A; Marshall RF; McClaughry LE
    Vet Med Small Anim Clin; 1981 Sep; 76(9):1319-24. PubMed ID: 6916555
    [No Abstract]   [Full Text] [Related]  

  • 17. Canine parvovirus: safety and efficacy of attenuated feline panleucopenia vaccine.
    Vet Rec; 1980 Jun; 106(24):512-3. PubMed ID: 6254234
    [No Abstract]   [Full Text] [Related]  

  • 18. Studies on canine parvovirus infections: development of an inactivated vaccine.
    Eugster AK
    Am J Vet Res; 1980 Dec; 41(12):2020-4. PubMed ID: 7212436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficiency and safety of an inactivated feline parvovirus vaccine against canine parvovirus infection.
    Chapek ML; McClaughry LE; Wilkins LM
    Mod Vet Pract; 1980 Mar; 61(3):261-3. PubMed ID: 7366579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Three-year duration of immunity in dogs following vaccination against canine adenovirus type-1, canine parvovirus, and canine distemper virus.
    Gore TC; Lakshmanan N; Duncan KL; Coyne MJ; Lum MA; Sterner FJ
    Vet Ther; 2005; 6(1):5-14. PubMed ID: 15906266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.